INSIGHTS ON CLINICAL TRIAL DESIGN

• How Humans And AI Collaborate To Improve Quality, Speed, And Agility In Study Build

  Learn how combining human expertise with AI can improve speed, consistency, and oversight while identifying issues earlier and supporting higher-quality clinical trial execution.

• From Weeks To Days: An Innovative Approach To Patient Recruitment

  Discover how AI-driven, personalized communication can break linguistic and literacy barriers to make patient recruitment faster, more inclusive, and 30% more effective.

• Critical Inputs For Configuring An RTSM

  Uncover why clearly defined visit schedules and dispensing events are essential in RTSM design — and how resolving protocol ambiguity early prevents downstream complexity across systems and sites.

• At The Crossroads Of Data: eCOA And Sensors Converging For Novel Insights

  Leveraging sensors and eCOA addresses increasing clinical trial complexity and ensures a more efficient and effective study design.

• What Everest Group's RTSM Recognition Means For The Industry

  12/5/2025

  RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.

• The Latest Generation Of Patient Recruitment Has Arrived

  10/29/2025

  In the final session of our three-part webinar series, we explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.

• The Case For Parallel Processing In Clinical Trial Start-Up

  1/26/2026

  Stop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.

• Real-Time Trials Need Real-Time Data You Can Trust

  7/30/2026

  The FDA just kicked off real-time clinical trials with AstraZeneca and Amgen. But speed means nothing if the underlying data is inconsistent.

• Pioneering The End-To-End Decentralized Trial Experience

  4/16/2025

  This collaboration highlights the potential of decentralized clinical trials (DCTs) to transform trial execution, as well as offering a replicable model for future research.